423 related articles for article (PubMed ID: 11114103)
1. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
[TBL] [Abstract][Full Text] [Related]
2. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity among patients with latent autoimmune diabetes in adults.
Maruyama T; Nakagawa T; Kasuga A; Murata M
Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
[TBL] [Abstract][Full Text] [Related]
4. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
[TBL] [Abstract][Full Text] [Related]
5. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
[TBL] [Abstract][Full Text] [Related]
6. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
Martinka E; Rončáková M; Mišániková M; Davani A
Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
[TBL] [Abstract][Full Text] [Related]
8. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
Littorin B; Sundkvist G; Hagopian W; Landin-Olsson M; Lernmark A; Ostman J; Arnqvist HJ; Blohmé G; Bolinder J; Eriksson JW; Lithner F; Scherstén B; Wibell L
Diabetes Care; 1999 Mar; 22(3):409-12. PubMed ID: 10097919
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
[TBL] [Abstract][Full Text] [Related]
10. Type 1 diabetes in insulin-treated adult-onset diabetic subjects.
Willis J; Scott R; Brown L; Zimmet P; MacKay I; Rowley M
Diabetes Res Clin Pract; 1998 Oct; 42(1):49-53. PubMed ID: 9884033
[TBL] [Abstract][Full Text] [Related]
11. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.
Singh AK; Bhatia E; Dabadghao P; Bhatia V; Gellert SA; Colman PG
Diabet Med; 2000 Apr; 17(4):275-80. PubMed ID: 10821293
[TBL] [Abstract][Full Text] [Related]
12. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.
Davis TM; Zimmet P; Davis WA; Bruce DG; Fida S; Mackay IR
Diabet Med; 2000 Sep; 17(9):667-74. PubMed ID: 11051287
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
[TBL] [Abstract][Full Text] [Related]
15. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
[TBL] [Abstract][Full Text] [Related]
16. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
17. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
18. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
Borg H; Gottsäter A; Fernlund P; Sundkvist G
Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
[TBL] [Abstract][Full Text] [Related]
19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
20. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]